J apan is facing a rapidly aging society. Twenty-five percent of the population was over 65 years old in 2013, the highest percentage of this age group in the world. 1 Locomotive dysfunction caused by osteoporosis and spinal stenosis reduces quality of life and adaptation to daily life of the elderly. [2] [3] [4] [5] Spinal stenosis is a painful, debilitating condition with a variable course that primarily affects older adults. 4 It is one of the most commonly diagnosed conditions in adults of age 65 years and above, whereas the natural history of spinal stenosis is reported to be relatively benign. Standard treatments for spinal stenosis include physical therapy, pharmacotherapy, nerve block (epidural injection), and surgical treatment. Although surgery for spinal stenosis was the top form of orthopedic spinal surgery in Japan, 6 problems of operation-related complications and medical costs were examined.
To assure a better healthcare provision for spinal stenosis, it is desirable to understand the number of patients who require medical attentions and their treatment status. It has been, however, difficult to obtain such data at a population level: only a few reports from small populations have described the prevalence of spinal stenosis without depicting their therapeutic profiles. 10, 11 Japan has had universal health coverage for decades through its employee-and community-based social health insurance, and recently its elderly health insurance. 12 Under such systems, health insurance claims data have recently become to be utilized to identify the healthcare profiles, including patient counts and treatment status, at large population levels. 13 In this study, we described the number of patients with spinal stenosis and their treatment profiles by using health insurance claims data at a large community level.
MATERIALS AND METHODS

Study Population and Data Sources
This study was done in a prefecture in south-western Japan where 1.8 million people lived in 7404 square kilometers in 2010. Among 47 prefectures in Japan, the prefecture ranks around the middle in terms of population size (21st), the elderly population (20th), and average per capita income (39th).
The study population was all the beneficiaries of National Health Insurance (NHI) and Late-stage Elderly Health Insurance (LEHI) in the prefecture. The health insurance system in Japan is broadly classified into three kinds of public systems: NHI, Employees' Health Insurance (EHI), and LEHI. 12 NHI is generally operated at the municipal level and covers self-employed workers, unemployed people, and retired people. EHI is for salaried workers in companies and factories and their dependent families. NHI and EHI cover the eligible people of age < 75 years; LEHI covers all people of age ! 75 years, irrespective of their employment or dependence status. Under the universal coverage system, all registered residents of Japan must enroll in the appropriate health insurance system.
We used claims data of NHI and LEHI for the prefecture from April 2010 to March 2011. Medical facilities issue NHI and LEHI claims monthly, to be collected and reviewed by the review and payment organization in the prefecture where patients registered their addresses.
14 Under a research agreement with us, the organizations computerized and combined monthly claims data from the whole prefecture for each patient by using a unique beneficiary identification number when two or more claim forms were issued for a patient in a single month. After this process was complete, we obtained data in an anonymous format.
We limited our study population to the beneficiaries who were continuously covered by NHI or LEHI of the prefecture throughout the study period to exclude the influence of population movement, including moving from/to other prefectures, deaths, and change of insurance program. The total study population size was 699,723 (467,706 in NHI; 232,017 in LEHI), which accounted for 97.4% of the total beneficiaries of NHI and LEHI as of April 2010. Our study population covered 38.5% of the total population and 91.4% of those ! 75 years of the prefecture according to the national census in October 2010. Summary of the study population was shown in Table 1 . 
Case Definitions
The diagnoses on the claim forms were coded with the International Classification of Diseases, 10th version (ICD-10). We considered patients to have spinal stenosis if they had at least one diagnosis code in at least one month during the study period, namely M4800, M4802, M4804, M4806, M4808, and M4809 in the ICD-10, excluding suspected or unconfirmed diagnosis of spinal stenosis. We defined the study period as 1 year to obtain a closer estimate of 1-year prevalence by reducing the effect of the visit interval. In Japan, most of the chronic diseases including spinal stenosis are managed at outpatient clinics, and the average number of patient visits to physicians is very high compared with other developed countries. According to the Patient Survey in 2011, average visit interval among the patients with dorsopathies (M40-M54 in ICD-10) was 5.6 days. 15 Therefore, we could cover most of the chronic patients who have been diagnosed as spinal stenosis previously and the new cases within the study period.
Regarding the insurance claims, once the patient is diagnosed as spinal stenosis, the name of the diagnosis will appear on the claims form continuously on the claims for the subsequent visits until the physician marks one of three outcome options: cure, discontinuation, or death. The ''cure'' would not be selected because spinal stenosis is a chronic condition. The ''discontinuation'' is selected when the patients have changed healthcare facilities. In this case, the data on the insurance claims from the new facilities would be recorded in the same database as long as they are covered by the same insurer-that is, they live in the same municipality. The diagnosis of spinal stenosis remains on the claims even when the patients visit healthcare facilities just for follow-ups without any specific treatments.
Patient Characteristics, Comorbid Conditions, and Treatments
As for patient characteristics, we collected age as of April 2010, sex, comorbid conditions potentially related to spinal stenosis, including achondrodysplasia, disk herniation, spondylolisthesis, spondylolysis, postlaminectomy, Paget's Disease, spondylosis, and osteoporosis. Each disease and the ICD-10 codes are shown in the appendix, http://links.lww.com/BRS/B118. To describe the therapeutic profile, we collected the information on prescriptions, treatments and surgeries those were covered by insurance. Prescriptions for analgesics, prostaglandin E1 (limaprost alfadex), and three types of nerve block (epidural block, ganglion block, and transsacral block) were surveyed in the claims data as nonsurgical treatment. As there is no code for epidural steroid injections (ESIs), patients were regarded to have received ESIs if the epidural block and the prescription of steroids for injection were recorded within a single claim form. Indirect traction, thermotherapy, electrotherapy, electromicrowave therapy, and phototherapy were classified as physical therapy. Laminectomy, vertebral fixation, neurolysis, and endoscopic procedure were defined as surgical treatments of spinal stenosis. Cognitive behavior therapy was also investigated though it was not covered by the insurance as a treatment for spinal stenosis in Japan. The patients were classified as ''no treatment'' when they did not receive any of the above-mentioned treatments during the study period.
Analysis
We calculated the number of patients with spinal stenosis per 1000 beneficiaries in total and by sex and 5-year age class. Then, the proportions of place of residence (urban or rural), positions of lesion, and major comorbid and vertebra-related conditions were described for the patients of spinal stenosis. We also described age-sex specific therapeutic profile by calculating the proportions of the patients having received each type of treatment. We used MySQL Community Server version 5.5.31 (ORACLE Inc., US) for data management and analysis.
RESULTS
The number of patients with spinal stenosis in the study population was 52,889 or 76 per 1000 beneficiaries ( Table 2 ). The number of patients per 1000 beneficiaries among those ! 65 years, ! 75 years, and ! 85 years were 128, 155, and 152, respectively. The age-specific number of patients per beneficiaries showed unimodal distribution in both males and females: it gradually increased until their 60s and doubled when they reached 70s, then turned to decrease at the very old age (Figure 1 ). Spinal stenosis was more prevalent in females (83/1000) than in males (67/ 1000), but the relationship among them was reversed for those ! 85 years. The peak age group was 95 to 99 years in males(191/1000), and 80 to 84 years in females (160/1000) ( Figure 1 ).
Of 52,889 patients with spinal stenosis, 89.6% were lumber stenosis (Table 3) . Common comorbid conditions were hypertension (46.2%), diabetes mellitus (22.7%), cerebrovascular diseases (19.8%), ischemic heart diseases (18.4%), and cancer (16.0%). Osteoporosis (40.1%) and spondylosis (36.6%) were common vertebra-related conditions.
Analgesics and prostaglandin E1 were prescribed to 60% and 22% of the patients with spinal stenosis, respectively (Table 4) . Only analgesics, only prostaglandin E1, or both were prescribed to 40%, 2%, or 20%, respectively. Physical therapy was used for 19% and nerve block for 8%, including ESIs for 4%. Surgical treatments were performed for 0.4%, including minimally invasive microscopic surgery for 0.06% (30 patients). No patient received cognitive behavior therapy. The rest of the 17,424 (33%) patients did not receive any of these treatments. Regarding the difference of treatments by age and sex, the older the patients were, the more likely they were to be prescribed analgesics and/or prostaglandin E1. These patterns were found more notably in females than in males. On the other hand, the younger the patients were, the more likely they were to receive nerve blocks and surgeries.
DISCUSSION
The current study is the first to show the age-sex specific number of patients with spinal stenosis in a large-scale population, and we found that there was relatively large number of patients with spinal stenosis who required some kind of medical attentions during the study period, especially in the very old age groups. The number of patients per beneficiaries was similar or slightly higher compared with Others the previous reports of the prevalence in smaller populations in Japan (11.8%-13.4% in males and 13.3%-19.4% in females). 10, 11 The current study is based on health insurance claims data in a large-scale population, and is a complete count survey for the elderly ! 75 years. Whereas previous studies were composed of volunteer participants, our study is a comprehensive survey of a general population. Therefore, this study presents more reliable values for the number of patients with spinal stenosis.
In this study, the number of patients with spinal stenosis per beneficiaries among males and females increased as their ages advanced. Spinal stenosis was more prevalent in females than in males, but the relationship among them was reversed for those ! 85 years. There are some possible reasons for this sex difference. First, males are more likely to complain of the symptoms of spinal stenosis because healthy elderly males are more physically active than females. 16 A population-based study in Japan also showed that elderly females were more likely than males to require long-term care in the care facilities because of impaired activities of daily living. 17 Another possible reason is a disparity in healthcare access between males and females. A research suggested that lower utilization of health and long-term care program in elderly females than in males because of lower availability of transportation service and fewer caregivers. 18 The result from the recent Patient Survey, which showed the rate of estimated outpatient patient in females were about 80% of that in males among those ! 90 years, 15 also supports this difference.
Although many clinical reports of spinal stenosis exist, few reports have described the whole profile of treatment on a population base. Surprisingly, only 0.4% of patients underwent spinal surgery. Prostaglandin E1 has been shown to treat pain and improve quality of life [19] [20] [21] and is prescribed popularly in Japan. We speculate that the symptoms and treatments vary widely among patients with spinal stenosis, and surgical treatments are least preferable in Japan. The high proportion of ''no treatment'' patients was another remarkable finding. This is probably because we included the patients who developed spinal stenosis before the study period and followed-up without specific treatments during the study period. We should also address the possibility that some of these patients might have received nonstandard treatment not covered in this study.
We found that females with spinal stenosis were more likely to receive analgesics and/or prostaglandin E1 than 24 (15) 748 (17) 2525 (20) 6149 (24) 2324 (24) 11,770 (22) Nerve block 13 (8) 440 (10) 1209 (10) 2132 (8) 485 (5) 4279 (8) (1) 208 (5) 575 (5) 957 (4) 235 (2) 11 (11) 391 (18) 965 (18) 1935 (19) 583 (19) 3885 (18) Nerve block 8 (8) 242 (11) 582 (11) 942 (9) 164 (5) 1938 (9) ESIs Ã 1 (1) 111 (5) 273 (5) 406 (4) 78 (2) 13 (21) 357 (17) 1560 (22) 4214 (27) 1741 (26) 7885 (25) Nerve block 5 (8) 198 (9) 627 (9) 1190 (8) 321 (5) 2341 (7) ESIs Ã 1 (2) 97 (5) 302 (4) 551 (3) 157 (2) 1108 ( males especially in older age group. This is consistent with previous findings that showed higher analgesics prescription rate in elderly females than in males. 22 Considering the results that surgical treatments were provided more for males than females, this difference might have been amplified by physical frailty and resulting lower indication of invasive treatments in females patients.
Lotan first reported linking spinal stenosis and diabetes mellitus or hypertension, describing that the prevalence of hypertension and diabetes mellitus among patients with spinal stenosis was 23.2% and 13.6%, respectively, compared with 7.8% and 5.9% in the general population. 23 Similarly, Uesugi 24 showed a close association between diabetes and hypertension in the patients of age 50 to 69 years with lumbar spinal. In this study, hypertension and diabetes were found in 46.2% and 22.7% of the patients, respectively, and both were higher than that of the Japanese general population over 75 years (35.4% and 7.7%, respectively). 25 However, the percentages of tentative diagnosis for hypertension or diabetes in claims were reported to be not negligible, leading to an overestimation of the prevalence of these diseases. 26 Further studies need to clarify the relationship between spinal stenosis and diabetes or hypertension.
There are several limitations in this study. First, the number of patients with spinal stenosis based on claims data did not indicate the true prevalence of the disease because we only covered the patients who sought medical care. This is an intrinsic limitation of the claims data, but we could, at least, cover the cases required clinical attentions. At the same time, there is a possibility of overestimation because of tentative diagnosis, a rule-out diagnosis for reimbursement purpose of expensive or specific diagnosis tests. 26 However, spinal stenosis is less likely to be a tentative diagnosis because it does not require any expensive tests. Second, we could not consider severity of spinal stenosis and indications for the treatments. Spinal stenosis is diagnosed with clinical symptoms such as pain and walking disability, and morphological tests such as CT and MRI are less likely to be done in nonserious cases. Therefore, the diagnosis of spinal stenosis contains a wide spectrum of the disease, such as the degree of conditions. Third, we could not confirm whether the treatments were used for spinal stenosis. Some treatments, including analgesics, prostaglandin E1, and steroid injections, might have been used for other diseases, which could result in overestimation of the treatment profile. However, this would be minimal for more disease-specific treatments like surgery. Fourth, the findings of this study were not necessarily representative of the population of age < 75 years in the prefecture. The current findings, however, still have significant clinical relevance, as we covered almost all of the residents at the peak age of spinal stenosis. Finally, the results of the current study could not be generalizable to the other populations, though those might be recognized as the situations in the average prefectures in Japan.
Analysis of insurance claims data could be used to survey the frequency and treatment of some diseases in a nationalized healthcare system model. Whereas the Patient Survey, a nationwide sampling survey of patients, is held every 3 years in Japan, and several cohort studies are carried out on a community basis, these have strengths and weaknesses. Health insurance claims data would make rapid and costeffective contributions to survey the frequency and the therapeutic profiles of diseases. In the current study, we utilized a large-scale claims data to have found that spinal stenosis was highly prevalent especially in elderly people and most of the patients received nonsurgical treatments. Healthcare practitioners and policy makers should recognize potential significance of spinal stenosis in the aging society.
Key Points
The number of patients with spinal stenosis per 1000 beneficiaries was 76, and those for the population of age ! 65, ! 75, and ! 85 years were 128, 155, and 152, respectively, based on the large-scale population-based health insurance claims data in Japan. Spinal stenosis was more prevalent in females than in males, but the relationship among them was reversed for those ! 85 years. Analgesics, prostaglandin E1, or both were prescribed to 40%, 2%, or 20% of the patients with spinal stenosis, but only 0.4% received surgical treatment. Health insurance claim data could be a useful source of surveillance of such common diseases as spinal stenosis.
